EP 1202620 A1 20020508 - ANTI-INFLAMMATORY THERAPY FOR INFLAMMATORY MEDIATED INFECTION
Title (en)
ANTI-INFLAMMATORY THERAPY FOR INFLAMMATORY MEDIATED INFECTION
Title (de)
ANTI-INFLAMATORISCHE THERAPIE FÜR INFLAMMATORISCH VERMITTELTE INJEKTIONEN
Title (fr)
THERAPIE ANTI-INFLAMMATOIRE POUR INFECTION A MEDIATION INFLAMMATOIRE
Publication
Application
Priority
- US 0013142 W 20000512
- US 13409199 P 19990514
Abstract (en)
[origin: WO0069255A1] Provided are methods for inhibiting the progression of an inflammatory mediated mucosal infection. The methods include administering an effective amount of an anti-inflammatory agent. Also provided are compositions and articles of manufacture for preventing, and inhibiting the activation and progression of a mucosal infection.
IPC 1-7
IPC 8 full level
A61K 9/02 (2006.01); A61F 6/04 (2006.01); A61F 6/06 (2006.01); A61F 6/14 (2006.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01); A61K 9/12 (2006.01); A61K 31/00 (2006.01); A61K 31/192 (2006.01); A61K 31/454 (2006.01); A61K 31/472 (2006.01); A61K 31/4725 (2006.01); A61K 31/496 (2006.01); A61K 31/513 (2006.01); A61K 31/536 (2006.01); A61K 31/5513 (2006.01); A61K 31/573 (2006.01); A61K 31/60 (2006.01); A61K 31/603 (2006.01); A61K 31/606 (2006.01); A61K 31/7072 (2006.01); A61K 31/708 (2006.01); A61K 31/7088 (2006.01); A61K 36/18 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 38/20 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); A61P 1/04 (2006.01); A61P 11/02 (2006.01); A61P 15/02 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR)
A61K 31/00 (2013.01 - EP); A61K 31/454 (2013.01 - EP); A61K 31/606 (2013.01 - EP); A61K 31/616 (2013.01 - EP); A61K 38/16 (2013.01 - KR); A61K 38/1793 (2013.01 - EP); A61K 38/2026 (2013.01 - EP); A61K 38/2066 (2013.01 - EP); A61K 38/2086 (2013.01 - EP); A61K 45/06 (2013.01 - EP); A61P 1/04 (2017.12 - EP); A61P 11/02 (2017.12 - EP); A61P 15/02 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 31/18 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61K 9/0031 (2013.01 - EP); A61K 9/0034 (2013.01 - EP); A61K 48/00 (2013.01 - EP)
Citation (search report)
See references of WO 0069255A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0069255 A1 20001123; WO 0069255 A8 20010322; AU 5010800 A 20001205; BR 0010546 A 20020305; CA 2368593 A1 20001123; CN 1353573 A 20020612; EP 1202620 A1 20020508; HK 1047216 A1 20030214; IL 146130 A0 20020725; JP 2002544210 A 20021224; KR 20020024587 A 20020330; MX PA01011606 A 20030910; PL 351710 A1 20030602; TR 200103271 T2 20020621
DOCDB simple family (application)
US 0013142 W 20000512; AU 5010800 A 20000512; BR 0010546 A 20000512; CA 2368593 A 20000512; CN 00807547 A 20000512; EP 00932379 A 20000512; HK 02109002 A 20021212; IL 14613000 A 20000512; JP 2000617724 A 20000512; KR 20017014522 A 20011114; MX PA01011606 A 20000512; PL 35171000 A 20000512; TR 200103271 T 20000512